Immunosuppression-related @entity75 are a significant problem in renal transplant recipients. Infections account for the majority of these manifestations. The aim of this study was to determine the spectrum of mucocutaneous @entity281 in renal transplant recipients. Over a period of three years, all the renal transplant recipients presenting with @entity75 (only with infectious etiology) were included in the study. Diagnosis was based on the clinical appearance and appropriate investigations like scraping for KOH, Tzanck smear, cultures, and skin biopsies whenever necessary. In order to study the temporal effect of immunosuppression on these mucocutaneous @entity281 , the @entity1 were divided into six groups -with durations of graft survival ranging from 0-2, 2-6, 6-12, 12-24, 24-60, and more than 60 months in Groups A-F, respectively. A total of 104 renal transplant recipients presented with 117 @entity281 . The mean age at presentation was 35.9 +/- 1.2 years (15-65 yrs), and the mean duration after the transplant was 23.3 +/- 3.5 months (1-175). The mean serum @entity1011 level at the time of clinical presentation was 1.4 +/- 0.07 mg/dl (0.7-6). Twenty-seven @entity1 were on a two-drug regimen, @entity617 and @entity500 , and the rest were on a three-drug regimen with @entity205 in addition. Out of the total of 117 @entity281 in 104 @entity1 , 57 were viral, 49 were fungal, and 8 were bacterial. Two @entity1 had @entity1908 and one had @entity3993 . The mean time interval for the occurrence of @entity281 after the transplant was earlier in @entity1 on three-drug immunosuppression (12.4 +/- 2.3 months) than in those on the two-drug regimen (51.3 +/- 1.8 months), (p<0.01). The @entity1800 had the shortest mean time interval for presentation following transplant, 15.8 +/- 1.2 months (p<0.05). We did not find any statistically significant difference with regard to age or sex of the @entity1 , duration after the transplant, or the pattern of infection. Careful examination of transplant @entity1 is essential for early detection and proper treatment, because the mucocutaneous @entity281 can have atypical morphologies and are likely to become extensive if not treated early.

The pattern of mucocutaneous XXXX in renal transplant recipients.

@entity1 :: ('9606', 'Species') :: ['patients'] @entity3993 :: ('MESH:D003551', 'Disease') :: ['cysticercosis'] @entity500 :: ('MESH:D001379', 'Chemical') :: ['azathioprine'] @entity75 :: ('MESH:D001927', 'Disease') :: ['mucocutaneous lesions'] @entity281 :: ('MESH:D007239', 'Disease') :: ['infections and infestations', 'infections'] @entity205 :: ('MESH:D016572', 'Chemical') :: ['cyclosporine'] @entity1908 :: ('MESH:D012532', 'Disease') :: ['scabies'] @entity1800 :: ('MESH:D014777', 'Disease') :: ['viral infections'] @entity1011 :: ('MESH:D003404', 'Chemical') :: ['creatinine'] @entity617 :: ('MESH:D011239', 'Chemical') :: ['prednisolone']
@entity281 :: (MESH:D007239,Disease) :: ['infections and infestations']
